title: Comments to: Yudkin J, Panahloo A, Stenhouwer C et al. (2000) the influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in type II diabetic subjects. Diabetologia 43: 1099-1106.
authors.forename: P
authors.initials: P
authors.lastname: Ebeling
authors.forename: M K
authors.initials: MK
authors.lastname: Heliövaara
mesh_terms: D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D006801:Humans; D007249:Inflammation / Q000097:blood*; D007328:Insulin / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D007328:Insulin; D013453:Sulfonylurea Compounds